Mehta API

Mehta API is an established Indian pharmaceutical manufacturer focused on the production of high-quality Active Pharmaceutical Ingredients (APIs) and advanced intermediates. Founded in 1982 and headquartered in Mumbai, the company operates multiple manufacturing sites that adhere to global regulatory standards, including USFDA, EDQM, and WHO-GMP. Their extensive product portfolio covers diverse therapeutic segments such as anti-diabetics, CNS stimulants, and anti-convulsants, with a strong market presence in both domestic and international markets. Mehta API emphasizes research and development to optimize chemical synthesis and ensure cost-competitive production. The company serves as a critical supplier to global generic pharmaceutical firms, supporting the development of finished dosage forms.